Moderna-Merck mRNA Cancer Vaccine Shows Promise

Published

By Andy Hsueh/Eric Gau

U.S. pharmaceutical companies Moderna and Merck say their trials show a new mRNA cancer vaccine treatment is effective in stopping the spread of skin cancer and they may seek accelerated approval.